# Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma

> **NCT02177370** · PHASE3 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 19 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fenoterol MDI
- **DRUG:** DSCG MDI

## Key facts

- **NCT ID:** NCT02177370
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1990-02
- **Primary completion:** 1996-10
- **Final completion:** —
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2014-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02177370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02177370, "Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02177370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*